Neogenomics Inc (NASDAQ: NEO) stock enjoyed a major increase of 12.9% on 10/1/25. The shares closed at $8.72. Moreover, trading volume in this advance was unusually high at 162% of normal. The stock has been […]
Stock Rating Downgrade The Value Trend Rating for Harsco Corp (NYSE: NVRI) weakened recently from B to C reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for HUTCHMED (China) Limited (NASDAQ: HCM) weakened during the last several trading days. HCM’s current Value Trend Rating is D and […]
Stock Rating Downgrade In the last week the Value Trend Rating for G Willi-Food International Ltd (NASDAQ: WILC) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action G Willi-Food […]
Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Eltek Ltd (NASDAQ: ELTK) improved during the last several trading days. ELTK’s current Value Trend Rating is C and the […]
ChromaDex Corp (NASDAQ: CDXC) stock closed at $7.89 on 10/1/25 after a major decline of -15.4%. Moreover, exceptionally high trading volume at 236% of normal accompanied the decline. The stock has declined -22.6% during the […]
Meaningful positive changes in fundamentals have recently occurred for Catalyst Pharmaceutical Inc (NASDAQ: CPRX): the consensus estimate for December, 2026 increased significantly, the consensus estimate for December, 2025 increased significantly, and significant quarterly earnings acceleration […]
Stock Rating Downgrade The Value Trend Rating for Bristol-Myers Squibb Co (NYSE: BMY) weakened in recent days from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included […]
Stock Rating Downgrade During the last several trading days the Value Trend Rating for Auburn National Bancorporation I (NASDAQ: AUBN) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action […]
Stock Rating Upgrade The Value Trend Rating for Ameriprise Financial Inc (NYSE: AMP) improved recently from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research